Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate + esketamine vs propofol + esketamine in pediatric anesthesia
ChiCTR2300076718Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative delirium (POD) and Emergence agitation (EA) comparing Remimazolam tosilate + esketamine with Propofol + esketamine (2 arms). Primary endpoints: PAED score and Incidence of adverse reactions during recovery. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
remimazolamesketaminepropofol
03
Conditions
postoperative delirium (POD)Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2300076718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076718.